Morana Jovan-Embiricos
10% owner at Cullinan Therapeutics; Director at Kalaris Therapeutics. Based in Waltham, Massachusetts.
- Rank
- 3732nd of 14,452
- Companies held
- 2
- Largest holding
- CGEM, 97.3% of total
- Latest SEC filing
- Jun 6, 2024
- Listed but not counted
- $11.8M
What the $30.5M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Cullinan Therapeutics CGEM Common Stock | Directly | 1,255,963 | $9.07 | $11.4M | 37.3% | Form 4, Aug 4, 2022 |
| Cullinan Therapeutics CGEM Common Stock | Through Globeways Holdings Ltd. Reported jointly by 2 insiders; split evenly | 568,263 | $9.07 | $5.2M | 16.9% | Form 4, Aug 2, 2022 |
| Cullinan Therapeutics CGEM Common Stock | Through F2 Bioscience I 2017 Ltd. | 537,392 | $9.07 | $4.9M | 16.0% | Form 4, Aug 2, 2022 |
| Cullinan Therapeutics CGEM Common Stock | Through F2-TPO Investments, LLC Reported jointly by 2 insiders; split evenly | 311,088 | $9.07 | $2.8M | 9.2% | Form 4, Aug 2, 2022 |
| Cullinan Therapeutics CGEM Common Stock | Through Morana Jovan-Embiricos | 207,803 | $9.07 | $1.9M | 6.2% | Form 4, Aug 2, 2022 |
| Cullinan Therapeutics CGEM Common Stock | Through F2 MG Ltd. Reported jointly by 2 insiders; split evenly | 162,667 | $9.07 | $1.5M | 4.8% | Form 4, Aug 2, 2022 |
| Cullinan Therapeutics CGEM Common Stock | Through F2 MC, LLC Reported jointly by 2 insiders; split evenly | 107,399 | $9.07 | $974K | 3.2% | Form 4, Aug 2, 2022 |
| Cullinan Therapeutics CGEM Common Stock | Through F2 Bio TD, LLC | 71,599 | $9.07 | $649K | 2.1% | Form 4, Aug 2, 2022 |
| Cullinan Therapeutics CGEM Common Stock | Through F2 GC, LLC Reported jointly by 2 insiders; split evenly | 52,381 | $9.07 | $475K | 1.6% | Form 4, Aug 2, 2022 |
| Kalaris Therapeutics KLRS Common Stock | Through F2 Capital I 2020 | 182,342 split-adjusted | $1.35 | $246K | 0.8% | Form 4, Jun 6, 2024 |
| Kalaris Therapeutics KLRS Common Stock | Shares held by ElevateBio LLC Reported jointly by 4 insiders; split evenly | 181,247 split-adjusted | $1.35 | $245K | 0.8% | Form 4, Jun 6, 2024 |
| Kalaris Therapeutics KLRS Common Stock | F2 MG Ltd. | 89,560 split-adjusted | $1.35 | $121K | 0.4% | Form 4, Jun 6, 2024 |
| Kalaris Therapeutics KLRS Common Stock | Shares held by F2 MC, LLC | 88,634 split-adjusted | $1.35 | $120K | 0.4% | Form 4, Jun 6, 2024 |
| Kalaris Therapeutics KLRS Common Stock | F2 Bioscience AV 2022 LLC | 37,725 split-adjusted | $1.35 | $51K | 0.2% | Form 4, Jun 6, 2024 |
| Kalaris Therapeutics KLRS Common Stock | Shares held by F2 TPO Investments, LLC | 29,047 split-adjusted | $1.35 | $39K | 0.1% | Form 4, Jun 6, 2024 |
| Kalaris Therapeutics KLRS Common Stock | Directly | 4,356 split-adjusted | $1.35 | $6K | 0.0% | Form 4, Jun 6, 2024 |
Share counts are the amounts Morana Jovan-Embiricos reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Morana Jovan-Embiricos's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Cullinan Therapeutics CGEM Common Stock | Through F2 Vision SCS Counted on the profile of the insider who holds these shares directly | 1,305,873 | $9.07 | $11.8M | — | Form 4, Jun 24, 2022 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 3729 | Jonathan G. Weiss Sr. Executive Vice President, Wells Fargo &. New York, NY | $30.6M |
| 3730 | David N. Watson CEO - Comcast Cable, Comcast. Tempe, AZ | $30.5M |
| 3731 | Omer Shai CMO, Wix.com | $30.5M |
| 3732 | Morana Jovan-Embiricos 10% owner, Cullinan Therapeutics. Waltham, MA | $30.5M |
| 3733 | Margaret Anne McAllister 10% owner, Hamilton Lane. Conshohocken, PA | $30.5M |
| 3734 | Gordon Crawford Director, Lionsgate Studios. Santa Monica, CA | $30.5M |
| 3735 | Robert A. Iger Chief Executive Officer, The Walt Disney. Burbank, CA | $30.5M |
Other Cullinan Therapeutics insiders
All CGEM insiders- Vision Scs F2$30.2M10% owner. #3763 overall
- Ansbert Gadicke$5.4M10% owner. #13301 overall
Questions
How much stock does Morana Jovan-Embiricos own?
Morana Jovan-Embiricos holds $30,527,632 in listed stock based on SEC filings and current prices, mostly Cullinan Therapeutics (CGEM). That ranks 3732nd on the Stock Rich List.
Is this Morana Jovan-Embiricos's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
Files jointly with Vision Scs F2.